Skip to content
MatchScript
Menu

Head-to-head · The Match Score

ShedRx vs Wisp

Both scored on the same six-factor Match Score. ShedRx wins this matchup with a 86 to 73 edge.

Higher Match Score

ShedRx

#4 · Grade B+

People who want an oral or sublingual option rather than weekly injections.

Visit ShedRx
VS

Wisp

#83 · Grade C

People who want branded injectables plus a sublingual semaglutide alternative.

Visit Wisp

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
84
81
Speed to Start
84
65
Formulary Match
92
90
Support Level
86
78
Flexibility
88
55
Transparency
82
72

Price, coverage & formulary

DetailShedRxWisp
Semaglutide$199/mo$225/mo (compounded oral)
Tirzepatide$299/mo$99/mo (starting dose, brand-name)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Match Score86 · B+73 · C
Winner: ShedRx

ShedRx edges out Wisp, 86 to 73 on the default Match Score. A weight-focused program that also offers an oral/sublingual route for the needle-averse.

Wisp is still a fair pick if its strengths line up with yours — best for: People who want branded injectables plus a sublingual semaglutide alternative.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full ShedRx reviewFull Wisp review

More head-to-heads

Or browse alternatives to ShedRx and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.